Dr R Shiffmann’s Asthmador: Relevant to Our Times, or a Snake Oil Remedy

Details

• Personal Author:
  Fedan, Jeffery S. ; Piedimonte G
• Description:
  We really would have liked to have been able to title this issue: 'Cures for Respiratory Diseases Found!' But we and you reading this issue at the time of its publication realize that this claim cannot be made. Alas, lung researchers have amassed a gargantuan level of knowledge about the diseases that are discussed in this issue: how patients present; the several morphological and pathophysiological changes that occur as the disease begins and progresses; some genetic, possibly etiologic, predispositions; and the mechanisms of action of most of the drugs that are used to prevent and/or ameliorate patient symptoms. Not that the 'cure' for these diseases lies ultimately in pharmacotherapy. At the outset we decided to limit the areas covered by this issue to asthma and cystic fibrosis. This was not done to slight other diseases such as tuberculosis, pneumonia, sarcoidosis and the many others, but because of the limitations of space. [Description provided by NIOSH]
• Subjects:
  Asthma Asthma, Occupational Fibrosis Lung Lung Diseases Occupational Health Respiratory System Respiratory Tract Diseases Safety
• Keywords:
  Bronchial-asthma Fibrogenesis Fibrogenicity Lung-disease Lung-disorders Pulmonary-system-disorders Respiratory-system-disorders
• ISSN:
  1471-4892
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  OSHA Region 3 ; West Virginia
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  HELD - Health Effects Laboratory Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  213-217
• Volume:
  10
• Issue:
  3
• NIOSHTIC Number:
  nn:20036975
• Citation:
  Curr Opin Pharmacol 2010 Jun; 10(3):213-217
• Contact Point Address:
  Jeffrey S Fedan, Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA
• Email:
  jsf2@cdc.gov
• Federal Fiscal Year:
  2010
• NORA Priority Area:
  Manufacturing
• Peer Reviewed:
  False
• Source Full Name:
  Current Opinion in Pharmacology
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:6a4d15dac83bd5108097df2e752260f41956cf4222c5d80aa07a3aa7b00c226b718db8a76c976ea193e1ae073d17ac261130c0115bd9e87af39a72eedc6a5d26
• Download URL:
  https://stacks.cdc.gov/view/cdc/188166/cdc_188166_DS1.pdf
• File Type:
  [PDF - 2.22 MB ]